These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16963622)

  • 41. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inhaled human insulin (Exubera): a revolution?].
    Daubresse JC; Sternon J
    Rev Med Brux; 2006; 27(6):493-7. PubMed ID: 17256415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity.
    Steil GM; Rebrin K; Mittelman SD; Bergman RN
    Diabetes; 1998 May; 47(5):714-20. PubMed ID: 9588441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of exogenous intermittent recombinant human PTH 1-34 administration and chronic endogenous parathyroid hormone excess on glucose homeostasis and insulin sensitivity.
    Anastasilakis AD; Efstathiadou Z; Plevraki E; Koukoulis GN; Slavakis A; Kita M; Avramidis A
    Horm Metab Res; 2008 Oct; 40(10):702-7. PubMed ID: 18553257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
    Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W
    Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080
    [No Abstract]   [Full Text] [Related]  

  • 52. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection.
    Cherrington AD; Neal DW; Edgerton DS; Glass D; Bowen L; Hobbs CH; Leach C; Rosskamp R; Strack TR
    Diabetes; 2004 Apr; 53(4):877-81. PubMed ID: 15047601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs.
    Kono T; Hanazaki K; Yazawa K; Ashizawa S; Fisher WE; Wang XP; Nosé Y; Brunicardi FC
    Artif Organs; 2005 Jan; 29(1):83-7. PubMed ID: 15644089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical pharmacology of human insulin (Novo) in normal subjects.
    Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG
    Diabetes Care; 1983; 6 Suppl 1():13-6. PubMed ID: 6133710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary insulin administration using the AERx insulin diabetes system.
    Thipphawong J; Otulana B; Clauson P; Okikawa J; Farr SJ
    Diabetes Technol Ther; 2002; 4(4):499-504. PubMed ID: 12396744
    [No Abstract]   [Full Text] [Related]  

  • 57. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
    Yang DB; Zhu JB; Zhu H; Zhang XS
    Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pattern of insulin delivery affects hepatic insulin sensitizing substance (HISS) action and insulin resistance.
    Reid MA; Lautt WW
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1068-74. PubMed ID: 15644948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.
    Edgerton DS; Moore MC; Winnick JJ; Scott M; Farmer B; Naver H; Jeppesen CB; Madsen P; Kjeldsen TB; Nishimura E; Brand CL; Cherrington AD
    Diabetes; 2014 Nov; 63(11):3946-54. PubMed ID: 24947349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.